Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon

Global Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

Executive Summary

Azoth Analytics has released a research report titled "Global Infectious Disease In vitro Diagnostics Market (2024 Edition)" which provides a complete analysis of the Global Infectious Disease In vitro Diagnostics industry in terms of market segmentation By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies), By Product Type (Instruments, Reagents, and Services) By End Users (Point of care, Central Laboratories, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Infectious Disease In vitro Diagnostics Market showcased growth at a CAGR of 2.45 % during 2020-2023. The market was valued at USD 65.86 Billion in 2023 which is expected to reach USD 80.31 Billion in 2030.

The global market for infectious disease in-vitro diagnostics encompasses a wide range of diagnostic tests and technologies used for the detection and management of infectious diseases. It
includes various assays, instruments, and reagents designed to identify pathogens, such as bacteria, viruses, fungi, and parasites, responsible for causing infectious illnesses in humans.
These diagnostic tools play a crucial role in disease surveillance, outbreak control, patient management, and public health interventions worldwide.

The market for infectious disease in-vitro diagnostics is driven by several factors, including the increasing prevalence of infectious diseases, rising demand for rapid and accurate diagnostic solutions, advancements in diagnostic techno*logies, and growing awareness about the importance of early disease detection and intervention. Additionally, factors such as globalization, urbanization, population growth, and environmental changes contribute to the spread of infectious pathogens, further fueling the demand for diagnostic tests and tools.

The market is characterized by intense competition among key players, including diagnostic manufacturers, biotechnology companies, and healthcare organizations. These companies are
continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:
• The report analyses the Global Infectious Disease In vitro Diagnostics Market by Value (USD Billion).
• The report presents the analysis of Global Infectious Disease In vitro Diagnostics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Global Infectious Disease In vitro Diagnostics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other Technologies)
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By Product Type (Instruments, Reagents, and Services).
• The report analyses the Global Infectious Disease In vitro Diagnostics Market By End Users (Point of care, Central Laboratories, and Other End Uses).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Technology, By Product Type and By End User.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include QIAGEN, F. Hoffmann-La Roche AG, OraSure technologies, PerkinElmer Inc., Abbott Laboratories, Thermo Fisher, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation, and Bio-Rad Laboratories

Table of Content

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Analyst Recommendations
2.1 Investment in Education and Training
2.2 Leveraging Artificial Intelligence for Advancements in Infectious Disease In-Vitro Diagnostics

3. Global Infectious Disease In vitro Diagnostics Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Global Infectious Disease In vitro Diagnostics Market
3.2 Global Prevalence of Infectious Disease, 2019
3.3 Global Incidence of Infectious Disease, 2019
3.4 New cases of tuberculosis with uncertainty intervals, World (2020-2022)
3.5 SARS-Cov-2 Tests: Volumes 2020
3.6 Global Infectious Disease In vitro Diagnostics Market: Dashboard
3.7 Global Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
3.8 Global Infectious Disease In vitro Diagnostics Market: Market Value Assessment
3.9 Assessment Degree of Impact of COVID-19 on Global Infectious Disease In vitro Diagnostics Market
3.10 Global Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
3.10.1 Global Infectious Disease In vitro Diagnostics Market, By Technology Overview
3.10.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By Technology
3.10.3 Global Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.4 Global Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.5 Global Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
3.10.6 Global Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
3.11 Global Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
3.11.1 Global Infectious Disease In vitro Diagnostics Market, By Product Type Overview
3.11.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By Product Type
3.11.3 Global Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.4 Global Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
3.11.5 Global Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
3.12 Global Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
3.12.1 Global Infectious Disease In vitro Diagnostics Market, By End-users Overview
3.12.2 Global Infectious Disease In vitro Diagnostics Market Attractiveness Index, By End-users
3.12.3 Global Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
3.12.4 Global Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
3.12.5 Global Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Infectious Disease In vitro Diagnostics Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Infectious Disease In vitro Diagnostics Market: Historic and Forecast
5.1 Americas Infectious Disease In vitro Diagnostics Market: Snapshot
5.2 Americas Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.3 Americas Infectious Disease In vitro Diagnostics Market: Key Factors
5.4 Americas Infectious Disease In vitro Diagnostics Market: Segment Analysis
5.5 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
5.5.1 Americas Infectious Disease In vitro Diagnostics Market, By Technology Overview
5.5.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.5 Americas Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
5.6.1 Americas Infectious Disease In vitro Diagnostics Market, By Product Type Overview
5.6.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
5.7.1 Americas Infectious Disease In vitro Diagnostics Market, By End-users Overview
5.7.2 Americas Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.3 Americas Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.4 Americas Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
5.8 Americas Infectious Disease In vitro Diagnostics Market Segmentation: By Country
5.8.1 Americas Infectious Disease In vitro Diagnostics Market, by Country Overview
5.8.2 United States Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.2.1 United States Infectious Disease In vitro Diagnostics Market, By Technology
5.8.2.2 United States Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.2.3 United States Infectious Disease In vitro Diagnostics Market, By End-users
5.8.3 Canada Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.3.1 Canada Infectious Disease In vitro Diagnostics Market, By Technology
5.8.3.2 Canada Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.3.3 Canada Infectious Disease In vitro Diagnostics Market, By End-users
5.8.4 Rest of Americas Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.4.1 Rest of Americas Infectious Disease In vitro Diagnostics Market, By Technology
5.8.4.2 Rest of Americas Infectious Disease In vitro Diagnostics Market, By Product Type
5.8.4.3 Rest of Americas Infectious Disease In vitro Diagnostics Market, By End-users

6. Europe Infectious Disease In vitro Diagnostics Market: Historic and Forecast
6.1 Europe Infectious Disease In vitro Diagnostics Market: Snapshot
6.2 Europe Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.3 Europe Infectious Disease In vitro Diagnostics Market: Key Factors
6.4 Europe Infectious Disease In vitro Diagnostics Market: Segment Analysis
6.5 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
6.5.1 Europe Infectious Disease In vitro Diagnostics Market, By Technology Overview
6.5.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.4 Europe Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.5 Europe Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
6.6.1 Europe Infectious Disease In vitro Diagnostics Market, By Product Type Overview
6.6.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
6.7.1 Europe Infectious Disease In vitro Diagnostics Market, By End-users Overview
6.7.2 Europe Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.3 Europe Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.4 Europe Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
6.8 Europe Infectious Disease In vitro Diagnostics Market Segmentation: By Country
6.8.1 Europe Infectious Disease In vitro Diagnostics Market, by Country Overview
6.8.2 Germany Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.2.1 Germany Infectious Disease In vitro Diagnostics Market, By Technology
6.8.2.2 Germany Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.2.3 Germany Infectious Disease In vitro Diagnostics Market, By End-users
6.8.3 United Kingdom Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.3.1 United Kingdom Infectious Disease In vitro Diagnostics Market, By Technology
6.8.3.2 United Kingdom Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.3.3 United Kingdom Infectious Disease In vitro Diagnostics Market, By End-users
6.8.4 France Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.4.1 France Infectious Disease In vitro Diagnostics Market, By Technology
6.8.4.2 France Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.4.3 France Infectious Disease In vitro Diagnostics Market, By End-users
6.8.5 Italy Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.5.1 Italy Infectious Disease In vitro Diagnostics Market, By Technology
6.8.5.2 Italy Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.5.3 Italy Infectious Disease In vitro Diagnostics Market, By End-users
6.8.6 Spain Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.6.1 Spain Infectious Disease In vitro Diagnostics Market, By Technology
6.8.6.2 Spain Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.6.3 Spain Infectious Disease In vitro Diagnostics Market, By End-users
6.8.7 Rest of Europe Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.7.1 Rest of Europe Infectious Disease In vitro Diagnostics Market, By Technology
6.8.7.2 Rest of Europe Infectious Disease In vitro Diagnostics Market, By Product Type
6.8.7.3 Rest of Europe Infectious Disease In vitro Diagnostics Market, By End-users

7. Asia Pacific Infectious Disease In vitro Diagnostics Market: Historic and Forecast
7.1 Asia Pacific Infectious Disease In vitro Diagnostics Market: Snapshot
7.2 Asia Pacific Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Infectious Disease In vitro Diagnostics Market: Key Factors
7.4 Asia Pacific Infectious Disease In vitro Diagnostics Market: Segment Analysis
7.5 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
7.5.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology Overview
7.5.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.4 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.6 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
7.6.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type Overview
7.6.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
7.7.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users Overview
7.7.2 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.3 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.4 Asia Pacific Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
7.8 Asia Pacific Infectious Disease In vitro Diagnostics Market Segmentation: By Country
7.8.1 Asia Pacific Infectious Disease In vitro Diagnostics Market, by Country Overview
7.8.2 China Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.2.1 China Infectious Disease In vitro Diagnostics Market, By Technology
7.8.2.2 China Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.2.3 China Infectious Disease In vitro Diagnostics Market, By End-users
7.8.3 Japan Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.3.1 Japan Infectious Disease In vitro Diagnostics Market, By Technology
7.8.3.2 Japan Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.3.3 Japan Infectious Disease In vitro Diagnostics Market, By End-users
7.8.4 India Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.4.1 India Infectious Disease In vitro Diagnostics Market, By Technology
7.8.4.2 India Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.4.3 India Infectious Disease In vitro Diagnostics Market, By End-users
7.8.5 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.5.1 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Technology
7.8.5.2 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By Product Type
7.8.5.3 Rest of Asia Pacific Infectious Disease In vitro Diagnostics Market, By End-users

8. Middle East and Africa Infectious Disease In vitro Diagnostics Market: Historic and Forecast
8.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Snapshot
8.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Key Factors
8.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market: Segment Analysis
8.5 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By Technology
8.5.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Technology Overview
8.5.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Immunoassay, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Molecular Diagnostics, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Microbiology, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.5 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Other Technologies, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By Product Type
8.6.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By Product Type Overview
8.6.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Instruments, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Reagents, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Services, By Value, 2020H-2030F (USD Billion & CAGR)
8.7 Middle East and Africa Infectious Disease In vitro Diagnostics Market Segmentation: By End-users
8.7.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market, By End-users Overview
8.7.2 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Point of care, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.3 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Central Laboratories, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.4 Middle East and Africa Infectious Disease In vitro Diagnostics Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Infectious Disease In vitro Diagnostics Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Industry Ecosystem Analysis
10.1 Porter Analysis

11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Global Infectious Disease In vitro Diagnostics Market
11.4 Company Profiles
11.4.1 QIAGEN
11.4.2 F. Hoffmann-La Roche AG
11.4.3 OraSure technologies
11.4.4 PerkinElmer Inc.
11.4.5 Abbott Laboratories
11.4.6 Thermo Fisher
11.4.7 Becton, Dickinson and Company
11.4.8 Hologic, Inc.
11.4.9 Danaher Corporation
11.4.10 Bio-Rad Laboratories

12. About Us & Disclaimer
Healthcare and Pharmaceuticals

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 191
Healthcare and Pharmaceuticals

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 196
Healthcare and Pharmaceuticals

North America Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 194
Healthcare and Pharmaceuticals

Global Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3750   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 205
Healthcare and Pharmaceuticals

Chronic Kidney Disease Management Technology Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)

  Price : US$ 3500   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 167

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SP...
View More
Europe Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SPECT, P...
View More
North America Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (S...
View More
Global Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SPECT, P...
View More
Chronic Kidney Disease Management Technology Market Size And Share Analysis - Growth Trends And...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved